|
π
|
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group.
105 auth.
B. Lacas,
A. Carmel,
C. Landais,
Stuart J. Wong,
L. Licitra,
J. Tobias,
B. Burtness,
M. Ghi,
E. Cohen,
C. Grau,
G. Wolf,
R. Hitt,
R. CorvΓ²,
V. Budach,
Shaleen Kumar,
...
S. Laskar,
J. Mazeron,
L. Zhong,
W. Dobrowsky,
P. Ghadjar,
C. Fallai,
B. Zakotnik,
Atul Sharma,
R. Bensadoun,
M. G. Ruo Redda,
S. Racadot,
G. Fountzilas,
D. Brizel,
P. Rovea,
A. Argiris,
Z. Nagy,
Ju-Whei Lee,
C. Fortpied,
J. Harris,
J. Bourhis,
A. AupΓ©rin,
P. Blanchard,
J. Pignon,
D. Adelstein,
M. Alfonsi,
Y. Belkacemi,
V. Bar-Ad,
J. Bernier,
A. Bratland,
G. Calais,
B. Campbell,
J. Caudell,
S. Chabaud,
E. Chamorey,
D. Chaukar,
K. Choi,
O. Choussy,
L. Collette,
J. J. Cruz,
C. Dani,
E. Dauzier,
A. Forastiere,
P. Garaud,
V. GrΓ©goire,
A. Hackshaw,
E. Haddad,
B. Haffty,
A. Hansen,
S. Hayoz,
J. Horiot,
B. Jeremic,
T. Karrison,
J. Langendijk,
M. Lapeyre,
Γ. Lartigau,
T. Leong,
Q. Le,
Pablo Lee,
F. Lewin,
A. Lin,
A. Lopes,
S. Mehta,
J. Moon,
E. Moyal,
B. Occean,
P. Olmi,
R. Orecchia,
B. O'Sullivan,
J. Overgaard,
C. Petit,
H. Quon,
G. Sanguineti,
T. Satar,
J. Simes,
C. Simon,
C. Sire,
S. Staar,
C. Stromberger,
P. Strojan,
S. Temam,
D. Thomson,
A. Timochenko,
V. Torri,
V. Tseroni,
J. Vermorken,
E. Vokes,
J. Waldron,
K. Wernecke,
J. Widder,
B. Zackrisson
|
7 |
2021 |
7
π
|
|
π
|
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group.
18 auth.
A. Gronchi,
A. De Paoli,
C. Dani,
D. Merlo,
V. Quagliuolo,
G. Grignani,
G. Bertola,
P. Navarria,
C. Sangalli,
A. Buonadonna,
...
R. de Sanctis,
R. Sanfilippo,
A. D. Dei Tos,
S. Stacchiotti,
L. Giorello,
M. Fiore,
P. Bruzzi,
P. Casali
|
6 |
2014 |
6
π
|
|
π
|
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1β2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial
65 auth.
C. Tinterri,
D. Gentile,
W. Gatzemeier,
A. Sagona,
E. Barbieri,
A. Testori,
V. Errico,
A. Bottini,
E. Marrazzo,
C. Dani,
B. Dozin,
L. Boni,
P. Bruzzi,
B. Fernandes,
D. Franceschini,
...
R. Spoto,
R. Torrisi,
M. Scorsetti,
A. Santoro,
G. Canavese,
Olindo Custodero,
V. L. Troilo,
M. Taffurelli,
M. Cucchi,
V. Galluzzo,
C. Cabula,
R. Cabula,
M. Lazzaretti,
F. Caruso,
G. Castiglione,
S. Grossi,
Maria Saveria Tavoletta,
Camilla Rossi,
A. Curcio,
D. Friedman,
P. Fregatti,
C. Magni,
G. Tazzioli,
S. Papi,
R. Giovanazzi,
C. Chifu,
R. Bettini,
M. Pezzella,
S. Michieletto,
T. Saibene,
M. Roncella,
M. Ghilli,
A. Sibilio,
A. Cariello,
S. Coiro,
G. Falco,
E. Z. Meli,
L. Fortunato,
L. Ciuffreda,
R. Murgo,
Claudio Battaglia,
Luca Rubino,
N. Biglia,
V. Bounous,
F. Rovera,
C. Chiappa,
G. Pollini,
S. Mirandola,
G. Meneghini,
Francesco di Bartolo
|
6 |
2022 |
6
π
|
|
π
|
Combined regimen of cisplatin, doxorubicin, and Ξ±β2b interferon in the treatment of advanced malignant pleural mesothelioma
14 auth.
H. S. Parra,
L. Tixi,
F. Latteri,
S. Bretti,
M. Alloisio,
A. Gravina,
R. Lionetto,
P. Bruzzi,
C. Dani,
R. Rosso,
...
M. Cosso,
L. Balzarini,
A. Santoro,
A. Ardizzoni
|
5 |
2001 |
5
π
|
|
π
|
Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP).
14 auth.
H. S. Parra,
L. Tixi,
F. Latteri,
S. Bretti,
M. Alloisio,
A. Gravina,
R. Lionetto,
P. Bruzzi,
C. Dani,
R. Rosso,
...
M. Cosso,
L. Balzarini,
A. Santoro,
A. Ardizzoni
|
4 |
2001 |
4
π
|
|
π
|
Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment
16 auth.
C. Tinterri,
G. Canavese,
W. Gatzemeier,
E. Barbieri,
A. Bottini,
A. Sagona,
Giulia Caraceni,
A. Testori,
S. Di Maria Grimaldi,
C. Dani,
...
L. Boni,
P. Bruzzi,
B. Fernandes,
M. Scorsetti,
A. Zambelli,
D. Gentile
|
4 |
2023 |
4
π
|
|
π
|
Increasing dose of Continuous Infusion Ifosfamide and Fixed dose of Bolus Epirubicin in Soft Tissue Sarcomas. A Study of the Italian Group on Rare Tumors
11 auth.
S. Frustaci,
A. Buonadonna,
A. Romanini,
Alessandro Cornandone,
M. D. Palma,
T. Gamucci,
...
C. Verusio,
R. Lionetto,
C. Dani,
P. Casali,
A. Santoro
|
3 |
1999 |
3
π
|
|
π
|
Lack of Activity of Docetaxel in Soft Tissue Sarcomas: Results of a Phase II Study of the Italian Group on Rare Tumors
14 auth.
A. Santoro,
A. Romanini,
A. Rosso,
S. Frustaci,
A. Comandone,
G. Apice,
D. de Toma,
L. Dogliotti,
R. Lionetto,
C. Dani,
...
P. Bruzzi,
M. Piolini,
P. Bergnolo,
C. Verusio
|
3 |
1999 |
3
π
|
|
π
|
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials
12 auth.
P. Bossi,
R. Miceli,
M. Benasso,
R. CorvΓ²,
A. Bacigalupo,
G. Sanguineti,
...
C. Fallai,
M. C. Merlano,
G. Infante,
C. Dani,
Valerio Di Giannantonio,
L. Licitra
|
3 |
2018 |
3
π
|
